vimarsana.com
Home
Live Updates
Teleflex Receives FDA Clearance for the Wattson® Tempor
Teleflex Receives FDA Clearance for the Wattson® Tempor
Teleflex Receives FDA Clearance for the Wattson® Temporary Pacing Guidewire
Company expands Structural Heart Portfolio with the first commercially available bipolar temporary pacing guidewire designed specifically for use during transcatheter aortic valve replacement and... | June 7, 2023
Related Keywords
United States ,
Phoenix ,
Arizona ,
Lawrence Keusch ,
Evan Belle ,
Jake Newman ,
Exchange Commission ,
Strategy Development ,
Teleflex Incorporated ,
Phoenix Convention Center West ,
Structural Heart Portfolio ,
Temporary Pacing Guidewire ,
Structural Heart Summit ,
Phoenix Convention ,
Annual Report ,
Left Ventricular Rapid Pacing Via ,
Valve Delivery Guidewire ,
Transcatheter Aortic Valve ,
Use Not ,
Investor Relations ,
Teleflex Incorporated Stock Exchange ,
News ,
Information ,
Press Release ,
Company ,
Xpands ,
Structural ,
Heart ,
Portfolio ,
Ith ,
The ,
First ,
Commercially ,
Vailable ,
Bipolar ,
Temporary ,
Racing ,
Guidewire ,
Esigned ,
Specifically ,
Or ,
Tse ,
During ,
Transcatheter ,
Aortic ,
Valve ,
Eplacement Tfx Us8793691069 ,